First‐Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial
by msharanya@metabolon.com | Aug 3, 2026 | 0 comments
by msharanya@metabolon.com | Aug 3, 2026 | 0 comments
Recent Comments